ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC11806-500g |
|
13408-09-8 |
β-Glycerophosphate (sodium salt hydrate)
|
0 | C3H7O6P • 2Na [5H2O] | |
GC11806-25g |
|
13408-09-8 |
β-Glycerophosphate (sodium salt hydrate)
|
0 | C3H7O6P • 2Na [5H2O] | |
GC11806-100g |
|
13408-09-8 |
β-Glycerophosphate (sodium salt hydrate)
|
0 | C3H7O6P • 2Na [5H2O] | |
GC11805-25mg |
|
606-58-6 |
Toyocamycin
|
0 | C12H13N5O4 | |
GC11805-10mg |
|
606-58-6 |
Toyocamycin
|
0 | C12H13N5O4 | |
GC11805-5mg |
|
606-58-6 |
Toyocamycin
|
0 | C12H13N5O4 | |
GC11805-1mg |
|
606-58-6 |
Toyocamycin
|
0 | C12H13N5O4 | |
GC11804-5mg |
|
77482-44-1 |
2-Guanidinoethylmercaptosuccinic Acid
|
0 | C7H13N3O4S | |
GC11803-1mg |
|
— |
Pseudo RACK1
|
0 | C144H225N43O34S3 | |
GC11802-50mg |
|
151272-90-1 |
CP 135807
|
0 | C19H21N5O2 | |
GC11802-10mg |
|
151272-90-1 |
CP 135807
|
0 | C19H21N5O2 | |
GC11801-1mg |
|
86933-75-7 |
Neurokinin B (human, porcine)
|
0 | C55H79N13O14S2 | |
GC11800-25mg |
|
1140525-25-2 |
SB 290157 (trifluoroacetate salt)
|
0 | C22H28N4O4 • CF3COOH | |
GC11800-10mg |
|
1140525-25-2 |
SB 290157 (trifluoroacetate salt)
|
0 | C22H28N4O4 • CF3COOH | |
GC11800-5mg |
|
1140525-25-2 |
SB 290157 (trifluoroacetate salt)
|
0 | C22H28N4O4 • CF3COOH | |
GC11800-1mg |
|
1140525-25-2 |
SB 290157 (trifluoroacetate salt)
|
0 | C22H28N4O4 • CF3COOH | |
GC11799-100mg |
|
115066-14-3 |
CNQX
|
0 | C9H4N4O4 | |
GC11799-50mg |
|
115066-14-3 |
CNQX
|
0 | C9H4N4O4 | |
GC11799-25mg |
|
115066-14-3 |
CNQX
|
0 | C9H4N4O4 | |
GC11799-10mg |
|
115066-14-3 |
CNQX
|
0 | C9H4N4O4 | |